Physician profile
Ritwick Panicker
NPI 1619914546
$714.27
in general payments reported to CMS, 2019-2025
17 companies · $590 in 2025
The $590 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $124 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $614 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.28 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $142.76 | 2024-2025 | |
| Seagen INC. | $99.99 | 2025 | |
| Pfizer INC. | $74.32 | 2025 | |
| Merck Sharp & Dohme LLC | $50.53 | 2025 | Keytruda |
| Bayer Healthcare Pharmaceuticals INC. | $43.91 | 2025 | |
| Glaxosmithkline, LLC. | $40.10 | 2025 | Ojjaara |
| Astrazeneca Pharmaceuticals Lp | $33.87 | 2025 | Imfinzi |
| Genzyme Corporation | $32.00 | 2025 | |
| Adc Therapeutics America, INC. | $28.08 | 2025 | |
| Gilead Sciences, INC. | $25.50 | 2025 | Trodelvy |
| Stemline Therapeutics INC. | $25.05 | 2025 | Orserdu |
| Regeneron Healthcare Solutions, INC. | $23.82 | 2025 | Libtayo |
| Tactile Systems Technology INC | $23.08 | 2025 | Flexitouch Plus, Nimbl |
| Puma Biotechnology, INC. | $23.04 | 2025 | |
| Celgene Corporation | $18.85 | 2025 | Reblozyl |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $15.77 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $13.60 | 2025 | Opdualag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ritwick Panicker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.